TRIB3 and atherosclerosis: Our study on whole body genetic deletion of Trib3 in a non-diabetic model of atherosclerosis also promotes mechanisms associated with increased plaque stability, by a reduction in the advancement of the plaque, with increased collagen and fibrous cap thickness, thereby delineating the impact of systemic/metabolic challenges from local changes in plaque-resident cell phenotype and function.